EUVIMEDObjevte EUVIMED
Open access

Predictive Performance of Seven Clinical Surrogates of Visceral Adipose Tissue for Cardiovascular Mortality: A Sub‐Analysis of 102 385 Adults From the Mexico City Prospective Study

Jesús Ernesto Martínez-Luna, María Fernanda Suárez-Velázquez, Mario César Torres-Chávez, Guillermo C Cardoso-Saldaña, Juan Reyes-Barrera, Jaime Berumen, Pablo Kuri-Morales, Roberto Tapia-Conyer, Jesús Alegre-Díaz, Carlos A Fermín-Martínez, Jacqueline A Seiglie, Omar Yaxmehen Bello-Chavolla and 1 more

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71095 ↗

At a glance

Journal article in Diabetes, Obesity and Metabolism, 2026. Written by Jesús Ernesto Martínez-Luna and 12 co-authors. Institution: Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico. Major MEDLINE topics: Cardiovascular Diseases, Intra-Abdominal Fat. 55 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Visceral adipose tissue (VAT) has been associated with cardiovascular disease (CVD) mortality. However, the comparative performance of VAT‐related clinical surrogates remains poorly characterised.

Objectives

To evaluate the performance of seven VAT‐related clinical surrogates for predicting cause‐specific CVD mortality.

Methods

We analysed data from the Mexico City Prospective Cohort, a population‐based prospective cohort study, with baseline recruitment between 1998 and 2004 and ongoing mortality follow‐up. CVD mortality included deaths from cardiac, stroke‐related and other vascular causes. Seven VAT‐related surrogates (METS‐VF, CVAI, EVA, DAAT, LAP, VAI and DAI) were estimated using clinical, biochemical and anthropometric data at baseline. Associations with outcomes were evaluated using Cox regression models to estimate adjusted hazard ratios (aHR). Discrimination was assessed with Harrell's C‐statistic (Cs) and calibration with slope plots.

Results

In a subsample of 102 385 participants without diabetes (median age: 47 years; 67% female) followed through a median of 20.13 years, 4068 (3.97%) died from any CVD causes. An increase in 1‐SD unit of METS‐VF (Cs: 0.73; aHR: 1.23, 95% CI: 1.18–1.29), EVA (Cs: 0.73; aHR: 1.19, 1.15–1.24), CVAI (Cs: 0.71; aHR: 1.19, 1.15–1.23) and DAAT (Cs: 0.63; aHR: 1.18, 1.14–1.23) was associated with CVD mortality and showed the highest predictive capacity and good calibration among the surrogates. Adding METS‐VF to the Globorisk score among individuals classified as intermediate risk slightly improved discrimination for CVD mortality.

Conclusions

In this large cohort of Mexican adults, four VAT‐related clinical surrogates, particularly METS‐VF, showed good discriminatory performance for long‐term CVD mortality. Our results could support future studies that could incorporate VAT estimation to improve CVD risk stratification.

Subjects

MeSH terms (MEDLINE)

Cardiovascular DiseasesIntra-Abdominal FatHumansFemaleMaleMiddle AgedMexicoProspective StudiesAdultBiomarkersPredictive Value of TestsRisk Factors

Author keywords

EpidemiologyMexicoMexico City Prospective Studyabdominalcardiovascular diseaseobesityrisk assessmentvisceral fat

Substances

Biomarkers

Authors and institutions

  • Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Mexico.
  • Experimental Research Unit, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico.
  • Research Division, Instituto Nacional de Geriatría, Mexico City, Mexico.

ORCID profiles: Neftali Eduardo Antonio-Villa

Funding

  • Wellcome Trust

Cite

APA

Martínez-Luna, J. E., Suárez-Velázquez, M. F., Torres-Chávez, M. C., Cardoso-Saldaña, G. C., Reyes-Barrera, J., Berumen, J., Kuri-Morales, P., Tapia-Conyer, R., Alegre-Díaz, J., Fermín-Martínez, C. A., Seiglie, J. A., Bello-Chavolla, O. Y., & Antonio-Villa, N. E. (2026). Predictive Performance of Seven Clinical Surrogates of Visceral Adipose Tissue for Cardiovascular Mortality: A Sub‐Analysis of 102 385 Adults From the Mexico City Prospective Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71095

Vancouver

Martínez-Luna JE, Suárez-Velázquez MF, Torres-Chávez MC, Cardoso-Saldaña GC, Reyes-Barrera J, Berumen J, et al. Predictive Performance of Seven Clinical Surrogates of Visceral Adipose Tissue for Cardiovascular Mortality: A Sub‐Analysis of 102 385 Adults From the Mexico City Prospective Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71095

BibTeX
@article{MartnezLuna2026,
  author = {Martínez-Luna, Jesús Ernesto and Suárez-Velázquez, María Fernanda and Torres-Chávez, Mario César and Cardoso-Saldaña, Guillermo C and Reyes-Barrera, Juan and Berumen, Jaime and Kuri-Morales, Pablo and Tapia-Conyer, Roberto and Alegre-Díaz, Jesús and Fermín-Martínez, Carlos A and Seiglie, Jacqueline A and Bello-Chavolla, Omar Yaxmehen and Antonio-Villa, Neftali Eduardo},
  title = {Predictive Performance of Seven Clinical Surrogates of Visceral Adipose Tissue for Cardiovascular Mortality: A Sub‐Analysis of 102 385 Adults From the Mexico City Prospective Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71095}
}
Start for free →